The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.
 
Arjun Vasant Balar
No Relationships to Disclose
 
Matthew I. Milowsky
No Relationships to Disclose
 
Peter H. O'Donnell
No Relationships to Disclose
 
Ajjai Shivaram Alva
No Relationships to Disclose
 
Marisa Kollmeier
No Relationships to Disclose
 
Tracy L Rose
No Relationships to Disclose
 
Sean Pitroda
No Relationships to Disclose
 
Samuel D. Kaffenberger
No Relationships to Disclose
 
Jonathan E. Rosenberg
No Relationships to Disclose
 
Kaitlyn Francese
No Relationships to Disclose
 
Tsivia Hochman
No Relationships to Disclose
 
Judith D Goldberg
No Relationships to Disclose
 
Sarah Griglun
No Relationships to Disclose
 
Dayna Leis
No Relationships to Disclose
 
Gary D. Steinberg
No Relationships to Disclose
 
James Wysock
No Relationships to Disclose
 
Peter B. Schiff
No Relationships to Disclose
 
Nicholas J. Sanfilippo
No Relationships to Disclose
 
Samir Taneja
No Relationships to Disclose
 
William C. Huang
No Relationships to Disclose